China NMPA Drug Inspection - Chongqing Baoyuantang Pharmaceutical Co., Ltd. - Prepared Chinese medicinal herbs (processed aconite, indigo naturalis)
China NMPA drug inspection for Chongqing Baoyuantang Pharmaceutical Co., Ltd. published November 24, 2017. Drug: Prepared Chinese medicinal herbs (processed aconite, indigo naturalis). On November 24, 2017, the State Administration for Market Regulation (formerly CFDA) announced that 14 batches of Tradit
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Chongqing Baoyuantang Pharmaceutical Co., Ltd. published November 24, 2017. Drug: Prepared Chinese medicinal herbs (processed aconite, indigo naturalis). On November 24, 2017, the State Administration for Market Regulation (formerly CFDA) announced that 14 batches of Tradit
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox